Covering minimally invasive vascular disease therapies and providing the latest clinical data, commentaries, and regulatory news.

Fort Washington, PA USA
Drs. Eric P. Wehrenberg-Klee and Suvranu Ganguli review recent influential studies in IO, covering combined locoregional therapies, bridging to liver transplantation, and ablation with immunotherapy or as definitive treatment for inoperable lung cancer. ow.ly/zo6P5102cLK
1
3
472
William A. Gray, MD (@DrBillGray) discusses how clinical evidence, anatomic suitability, operator experience, and patient preferences inform decisions about medical therapy and carotid revascularization. ow.ly/KS9M5101Jvc
1
2
493
Dr. Adnan H. Siddiqui (@_AdnanSiddiqui) introduces our latest issue, which explores evolving approaches to carotid artery disease in light of CREST-2 and advances in imaging, technique, and care delivery models. Plus: Updates in interventional oncology. ow.ly/nuiE51012w9
2
13
912
Protecting the entire interventional team from scatter radiation requires a comprehensive approach. Salus Scientific explores integrated solutions to improve radiation safety, reduce occupational risks, & support clinical workflows. #Sponsored @SalusActero ow.ly/qSRE51013qO
2
484
Isabella Garganese, BS, & Shakthi Kumaran Ramasamy, MD, speak with Ripal T. Gandhi, MD, about his career in IR, the evolution of interventional oncology, his research experience, & the importance of mentorship in developing the next gen of IR specialists. evtoday.com/articles/2026-se…
2
6
703
Drs. Lena E. Tran & Joshua A. Beckman examine the shifting paradigm in the medical management of PAD by reviewing lipid-lowering, antithrombotic, and cardiometabolic therapies, as well as the growing emphasis on comprehensive, guideline-directed care. ow.ly/JwjJ50ZZRue
1
1
3
541
Dr. Gregory A. Stanley considers the evolving role of lower-profile DCBs in complex femoropopliteal disease and presents a CLTI case demonstrating the lower-profile, extended-length IN.PACT 018 XL DCB in practice. | #Sponsored by @Medtronic ow.ly/265J50ZZlsK
1
2
501
Our latest issue examines the evolving landscape of lower extremity revascularization, with expert perspectives on PAD trial endpoints, drug-eluting therapies, vessel preparation, CFA disease, and modern medical management. ow.ly/SPUq50ZZ54F
4
590